These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25918149)

  • 1. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
    Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
    NDiaye JL; Cissé B; Ba EH; Gomis JF; Ndour CT; Molez JF; Fall FB; Sokhna C; Faye B; Kouevijdin E; Niane FK; Cairns M; Trape JF; Rogier C; Gaye O; Greenwood BM; Milligan PJ
    PLoS One; 2016; 11(10):e0162563. PubMed ID: 27764102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
    Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
    Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
    Tagbor H; Antwi GD; Acheampong PR; Bart Plange C; Chandramohan D; Cairns M
    Trop Med Int Health; 2016 Feb; 21(2):224-35. PubMed ID: 26578353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
    Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
    Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3-59 months in Nigeria: A propensity score-matched analysis.
    Huang S; Baker K; Ibinaiye T; Oresanya O; Nnaji C; Richardson S
    Trop Med Int Health; 2024 Aug; 29(8):668-679. PubMed ID: 38842452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
    Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P
    PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations in seasonal malaria chemoprevention.
    Chotsiri P; White NJ; Tarning J
    Trends Parasitol; 2022 Aug; 38(8):673-682. PubMed ID: 35688778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda.
    Kajubi R; Ainsworth J; Baker K; Richardson S; Bonnington C; Rassi C; Achan J; Magumba G; Rubahika D; Nabakooza J; Tibenderana J; Nuwa A; Opigo J
    Gates Open Res; 2023; 7():14. PubMed ID: 38196920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
    Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
    Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
    Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
    Mahaman Moustapha L; Adamou R; Ibrahim ML; Abdoulaye Louis Padounou M; Diallo A; Courtin D; Testa J; Ndiaye JLA
    Malar J; 2021 Jan; 20(1):1. PubMed ID: 33386070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study.
    Roh ME; Zongo I; Haro A; Huang L; Somé AF; Yerbanga RS; Conrad MD; Wallender E; Legac J; Aweeka F; Ouédraogo JB; Rosenthal PJ
    J Infect Dis; 2023 Oct; 228(7):926-935. PubMed ID: 37221018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso.
    Somé AF; Zongo I; Compaoré YD; Sakandé S; Nosten F; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3660-5. PubMed ID: 24733476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.
    Chandramohan D; Zongo I; Sagara I; Cairns M; Yerbanga RS; Diarra M; Nikièma F; Tapily A; Sompougdou F; Issiaka D; Zoungrana C; Sanogo K; Haro A; Kaya M; Sienou AA; Traore S; Mahamar A; Thera I; Diarra K; Dolo A; Kuepfer I; Snell P; Milligan P; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Ouédraogo JB; Dicko A; Greenwood B
    N Engl J Med; 2021 Sep; 385(11):1005-1017. PubMed ID: 34432975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
    Beshir KB; Muwanguzi J; Nader J; Mansukhani R; Traore A; Gamougam K; Ceesay S; Bazie T; Kolie F; Lamine MM; Cairns M; Snell P; Scott S; Diallo A; Merle CS; NDiaye JL; Razafindralambo L; Moroso D; Ouedraogo JB; Zongo I; Kessely H; Doumagoum D; Bojang K; Ceesay S; Loua K; Maiga H; Dicko A; Sagara I; Laminou IM; Ogboi SJ; Eloike T; Milligan P; Sutherland CJ
    Lancet Infect Dis; 2023 Mar; 23(3):361-370. PubMed ID: 36328000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.